Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol crossover trial in children with autism spectrum disorder
ACTRN12622000437763Phase 2Active, not recruiting
- Sponsor
- Deakin University
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cannabidiol in Autism Spectrum Disorder (ASD), sponsored by Deakin University. Started Oct 2022; status: active, not recruiting.
02
Drugs
cannabidiol
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ACTRN12622000437763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000437763.